A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia
Clinical trial NCT01773408 · COMPLETED
Trial details
- NCT number
- NCT01773408
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.